NCT00046527View on ClinicalTrials.gov

Study of ABI-007 and Taxol in Patients With Metastatic Breast Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

460

Participants

Timeline

Start Date

June 30, 2001

Conditions
Breast NeoplasmsMetastases, Neoplasm
Interventions
DRUG

ABI-007

Trial Locations (1)

27703

Abraxis Bioscience, Inc, Durham

Sponsors
All Listed Sponsors
lead

Celgene Corporation

INDUSTRY

NCT00046527 - Study of ABI-007 and Taxol in Patients With Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter